Literature DB >> 2406413

HIV-2 link to AIDS in West Africa.

I Romieu1, R Marlink, P Kanki, S M'Boup, M Essex.   

Abstract

To date, very little is known concerning the clinical spectrum of human immunodeficiency virus type 2 (HIV-2) infection, and the question as to whether HIV-2 will ultimately prove to be as pathogenic as human immunodeficiency virus type I (HIV-1) remains, as yet, unanswered. We reviewed the currently available reports of HIV-2 infection to assess what is known about the extent of HIV-2 pathogenicity as it compares to HIV-1 pathogenicity. There is evidence that HIV-2 is associated with AIDS. Most of this evidence, however, comes from descriptive case-report type data that do not meet the basic requirements for defining causality. The most significant problems are the lack of control groups and the absence of a documented temporal relationship with HIV-2 infection preceding the development of AIDS. Comparisons of the epidemiology and disease association between HIV-1 and HIV-2 in Africa may suggest relative pathogenic effects. Although certain comparisons between HIV-2 and HIV-1 are difficult to make, we conclude on the basis of existing data that the pathogenic effects and the natural history of HIV-2 are distinct from those of HIV-1.

Entities:  

Mesh:

Year:  1990        PMID: 2406413

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  13 in total

1.  Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau.

Authors:  W P Schmidt; M Schim Van Der Loeff; P Aaby; H Whittle; R Bakker; M Buckner; F Dias; R G White
Journal:  Epidemiol Infect       Date:  2007-06-11       Impact factor: 2.451

2.  No evidence of HIV-2 infection in subjects at risk for AIDS living in north-east Italy.

Authors:  A Del Mistro; A De Rossi; E Francavilla; M T Sartori; L Chieco-Bianchi
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

3.  Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.

Authors:  R L Willey; F Maldarelli; M A Martin; K Strebel
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast.

Authors:  K M De Cock; E Gnaore; G Adjorlolo; M M Braun; M F Lafontaine; G Yesso; G Bretton; I M Coulibaly; G M Gershy-Damet; R Bretton
Journal:  BMJ       Date:  1991-03-02

5.  Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey.

Authors:  P A Marx; Y Li; N W Lerche; S Sutjipto; A Gettie; J A Yee; B H Brotman; A M Prince; A Hanson; R G Webster
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry.

Authors:  S M Owen; D Ellenberger; M Rayfield; S Wiktor; P Michel; M H Grieco; F Gao; B H Hahn; R B Lal
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses.

Authors:  E G Shpaer; J I Mullins
Journal:  J Mol Evol       Date:  1993-07       Impact factor: 2.395

8.  Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.

Authors:  K Fransen; D E Pollet; M Peeters; I van Kerckhoven; G Beelaert; G Vercauteren; P Piot; G van der Groen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

9.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.

Authors:  F Gao; L Yue; D L Robertson; S C Hill; H Hui; R J Biggar; A E Neequaye; T M Whelan; D D Ho; G M Shaw
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

10.  Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal.

Authors:  C Donnelly; W Leisenring; P Kanki; T Awerbuch; S Sandberg
Journal:  Bull Math Biol       Date:  1993       Impact factor: 1.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.